Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data
Crossref DOI link: https://doi.org/10.1186/1472-6963-14-298
Published Online: 2014-07-09
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lang, Kathleen
Huang, Huan
Sasane, Medha
Federico Paly, Victoria
Hao, Yanni
Menzin, Joseph
License valid from 2014-07-09
Article History
Received: 7 August 2013
Accepted: 30 June 2014
First Online: 9 July 2014